全文获取类型
收费全文 | 135525篇 |
免费 | 4951篇 |
国内免费 | 965篇 |
专业分类
耳鼻咽喉 | 143篇 |
儿科学 | 2388篇 |
妇产科学 | 65929篇 |
基础医学 | 11277篇 |
口腔科学 | 294篇 |
临床医学 | 9087篇 |
内科学 | 7558篇 |
皮肤病学 | 780篇 |
神经病学 | 1739篇 |
特种医学 | 1703篇 |
外国民族医学 | 19篇 |
外科学 | 8812篇 |
综合类 | 8986篇 |
一般理论 | 16篇 |
预防医学 | 8346篇 |
眼科学 | 158篇 |
药学 | 4550篇 |
95篇 | |
中国医学 | 489篇 |
肿瘤学 | 9072篇 |
出版年
2023年 | 1860篇 |
2022年 | 3128篇 |
2021年 | 4366篇 |
2020年 | 4037篇 |
2019年 | 3342篇 |
2018年 | 3503篇 |
2017年 | 3609篇 |
2016年 | 3565篇 |
2015年 | 3804篇 |
2014年 | 7826篇 |
2013年 | 7136篇 |
2012年 | 7994篇 |
2011年 | 8316篇 |
2010年 | 6063篇 |
2009年 | 5597篇 |
2008年 | 5108篇 |
2007年 | 5949篇 |
2006年 | 5390篇 |
2005年 | 4992篇 |
2004年 | 4560篇 |
2003年 | 4412篇 |
2002年 | 4149篇 |
2001年 | 4033篇 |
2000年 | 3649篇 |
1999年 | 3123篇 |
1998年 | 807篇 |
1997年 | 774篇 |
1996年 | 687篇 |
1995年 | 700篇 |
1994年 | 490篇 |
1993年 | 485篇 |
1992年 | 2627篇 |
1991年 | 2617篇 |
1990年 | 2601篇 |
1989年 | 2418篇 |
1988年 | 2154篇 |
1987年 | 914篇 |
1986年 | 159篇 |
1985年 | 417篇 |
1984年 | 706篇 |
1983年 | 304篇 |
1982年 | 350篇 |
1981年 | 286篇 |
1980年 | 273篇 |
1979年 | 228篇 |
1978年 | 200篇 |
1977年 | 166篇 |
1976年 | 164篇 |
1975年 | 128篇 |
1973年 | 135篇 |
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
1.
2.
3.
《Diagnostic and interventional imaging》2022,103(10):464-471
PurposeThe purpose of this study was to retrospectively determine the incidence of early enlarging cavitation after percutaneous radiofrequency ablation (RFA) of lung tumor and identify risk factors associated with their occurrence.Patients and methodsA total of 245 patients (140 men, 105 women; mean age, 62.7 ± 11.8 [SD] years; age range: 31–87 years) with 605 lung tumors who were treated using 401 RFA sessions from April 2010 to March 2020 were included. Of which, 31 patients with 38 early enlarging cavitation and control group (151 patients with 228 tumors) were analyzed. Early enlarging cavitation was defined as cavities with an enlarged size (>3 cm) occurring on ablated lesions within seven days after RFA. Incidence of cavitation, risk and post-procedural factors of occurrence, major adverse events (AEs) that occurred in RFA sessions with cavitation, and course of cavitation were evaluated. AEs were classified using the CIRSE classification system for complications.ResultsThirty-eight cavities (6.3%, 38/605 tumors) in 31 patients occurred in an average of 3.1 ± 1.7 days (range, 1–7 days) after 32 RFA sessions. Distance from pleura ≥ 20 mm, contact with vessel ≥ 3 mm, multitined expandable electrode ≥ 3 cm, and bronchus ≥ 2 mm encompassed in the ablation zone were independent risk factors of occurrence. Fever ≥ 38.5 °C, white blood cell count ≥ 10,000/μl one day after RFA, and steroid therapy were independent post-procedural factors of occurrence. Twenty-four Grade 3 and two Grade 6 AEs occurred. Twenty-nine cavities disappeared within a mean duration of 111.9 ± 64.9 (SD) days (range: 44–274 days) and four remained with a mean follow-up of 279.2 ± 174 (SD) days; five patients were lost to follow-up.ConclusionsEarly enlarging cavitation occurs in 6.3% of lung tumors treated with RFA and are associated with 26 major AEs in 32 sessions. Aforementioned procedural factors and post-procedural inflammation were significant risk factors of occurrence. 相似文献
4.
Rizzo Giuseppe Pietrolucci Maria Elena Capponi Alessandra Mappa Ilenia 《The international journal of cardiovascular imaging》2022,38(5):1017-1019
The International Journal of Cardiovascular Imaging - 相似文献
5.
6.
《Brachytherapy》2022,21(3):273-282
ObjectiveTo report long-term oncological and toxicity outcomes after high-dose-rate brachytherapy (HDB) followed by oncologic surgery for patients with early-stage cervical cancer.Methods and MaterialsFrom 2005 to 2019, all patients treated with preoperative HDB at Antoine Lacassagne Cancer Center for early-stage (IB1-IB2-IIA - FIGO 2018) cervical cancer with local relapse risk factors were included. HDB was performed followed by hysterectomy. Oncological and toxicity outcomes were evaluated prospectively.ResultsWe identified 61 patients, with a median follow-up of 84 months. Posthysterectomy complete pathological response was observed in 46 patients (75.4%). Six patients (9.8%) experienced recurrence, including 4 local relapses (6.6%), and 2 deaths (3.3%) due to cervical cancer. Five-year local, nodal and metastatic relapse-free survivals were 94% (95% CI 87?100%), 96% (95% CI 90?100%) and 93% (95% CI 86?100%) respectively. Five-year overall survival was 98% (95% CI 95?100%). No grade ≥ 3 acute toxicity was observed, and 3 patients (4.9%) experienced grade 2 acute toxicity. One patient presented grade 4 late digestive toxicity, and 6 patients had grade 2 late toxicity. Only 1 patient still had grade 2 toxicity, after 9 years follow-up.ConclusionsTo our knowledge, we are reporting the longest follow-up of a preoperative HDB cohort. With similar oncological outcomes and less morbidity compared to primary surgery treatment followed more or less by adjuvant radiotherapy, HDB followed by hysterectomy could be a promising therapeutic option for early-stage cervical cancers with poor prognostic factors. 相似文献
7.
8.
《Current problems in cancer》2022,46(6):100896
Head and neck squamous cell carcinoma (HNSCC) is considered an immunosuppressive malignancy. Cross-talk between cancer cells and immune cells is modulated in part by CC ligand (CCL) chemokines, having a major effect on tumor progression. However, the predictive value and function of CCL family members in HNSCC have not been elucidated. Here, the predictive value of CCL members in cancer prognosis and Immune checkpoint blockade therapy response was investigated. CCL17 and CCL22 were screened as the key CCL chemokines in HNSCC through co-expression analysis. Further, the correlation between CCL17/CCL22 expression and cancer immune infiltration were evaluated based on TIMER and were validated by a set of scRNA-seq data. Moreover, the expression level of CCL17/CCL22 we evaluated to predict the response to Immune checkpoint blockade therapy in a panel of cancer types by using the TIDE database. Results indicated that CCL17/CCL22 had a high co-expression correlation and had a marginally statistical significance with the overall survival in HNSCC patients (P value = 0.057 and 0.055, respectively). Our findings showed high expression of CCL17/CCL22 was positively correlated with CD4+ T cell infiltration levels in HNSCCs and activate mTORC1 signaling pathway in CD4+ T cells. Further analysis from TIDE showed the high expression of CCL17/CCL22 might predict favorable responses to immune checkpoint blockade therapy in HNSCC patients. These findings provide an insight into the predictive roles of CCL17/CCL22 in HNSCC. 相似文献
9.
10.
《The journal of sexual medicine》2022,19(6):1035-1048
BackgroundRecently, the variability and heterogeneity of gender presentations in transgender youths have gained significant attention worldwide. Alongside this, specialized gender services have reported an increase in referrals of youths reporting non-binary identities. In Italy, studies investigating gender identity and expression in gender non-conforming youths are lacking, as are data regarding the non-binary population.AimThe present study aimed at dimensionally exploring how transgender and non-binary Italian adolescents identify and express their gender.OutcomesGender expression in trans binary youths and non-binary youths.MethodsThe Gender Diversity Questionnaire (GDQ; Twist & de Graaf, 2019) was used to investigate gender identity, gender fluidity, and gender expression in a sample of 125 adolescent patients from the Gender Identity Development Service (SAIFIP) in Rome and the Gender Incongruence Unit of the Careggi Hospital in Florence, between April 2019–June 2021.ResultsThe majority of participants (74.4%) identified as trans* binary and the remaining (25.6%) participants identified as non-binary. Trans binary participants reported a stable gender identity, whereas non-binary participants reported a more fluid gender identity across time and contexts. Almost all participants rated external appearance as important to their gender expression, yet trans binary participants attributed more importance to the body in this respect. Body discomfort and pubertal stage emerged as the most influential factors in participants’ experiences of gender. Participants who were assigned male at birth expressed significantly more desire for puberty blockers, whereas those who were assigned female at birth had a stronger desire to engage in breast/chest surgery. Non-binary participants sought different medical interventions relative to trans binary participants.Clinical ImplicationsThese results may be useful for clinicians working with transgender youths as they provide awareness regarding the features of young people who identify within and outside of binary constructions of gender.Strengths & LimitationsThis study provides useful data in gaining insight into understanding the variety of experiences and challenges of gender non-conforming youths. However as the sample was recruited from specialized services, it may not represent the entire gender non-conforming population in Italy.ConclusionThe results describe the range of gender identities and expressions among gender non-conforming youths attending gender specialized services in Italy, thereby improving our understanding of the variety of identities experienced and the specific medical needs of both trans binary and non-binary adolescents.Mirabella M, Piras I, Fortunato A, et al. Gender Identity and Non-Binary Presentations in Adolescents Attending Two Specialized Services in Italy. J Sex Med 2022;19:1035–1048. 相似文献